NCT/Study#
NCT05987241 /
A032103
MODERN: AN INTEGRATED PHASE 2/3 AND PHASE 3 TRIAL OF MRD-BASED OPTIMIZATION OF ADJUVANT THERAPY IN UROTHELIAL CANCER
DISEASE GROUP:
Genito-Urinary
current phase:
Phase II/III
STUDY STATUS:
Enrolling
Location:
Hackensack, NJ
For More information:
